AllianceBernstein’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Sell
12,900
-7,720
-37% -$142K ﹤0.01% 3074
2025
Q4
$283K Hold
20,620
﹤0.01% 2939
2025
Q3
$365K Buy
20,620
+1,300
+7% +$20.6K ﹤0.01% 2851
2025
Q2
$292K Buy
19,320
+6,400
+50% +$106K ﹤0.01% 2925
2025
Q1
$208K Sell
12,920
-1,580
-11% -$29.5K ﹤0.01% 2912
2024
Q4
$252K Hold
14,500
﹤0.01% 2955
2024
Q3
$254K Buy
14,500
+2,680
+23% +$45.7K ﹤0.01% 2978
2024
Q2
$132K Buy
+11,820
New +$111K ﹤0.01% 3088
2022
Q2
Sell
-21,349
Closed -$104K 3352
2022
Q1
$104K Sell
21,349
-1,500
-7% -$12.3K ﹤0.01% 3111
2021
Q4
$338K Hold
22,849
﹤0.01% 2912
2021
Q3
$494K Hold
22,849
﹤0.01% 2766
2021
Q2
$375K Buy
22,849
+1,000
+5% +$19K ﹤0.01% 2931
2021
Q1
$517K Sell
21,849
-3,600
-14% -$108K ﹤0.01% 2645
2020
Q4
$607K Hold
25,449
﹤0.01% 2501
2020
Q3
$300K Buy
25,449
+225
+0.9% +$2.42K ﹤0.01% 2810
2020
Q2
$264K Buy
25,224
+8,624
+52% +$77.7K ﹤0.01% 2933
2020
Q1
$119K Buy
16,600
+1,400
+9% +$14.5K ﹤0.01% 2921
2019
Q4
$204K Hold
15,200
﹤0.01% 2913
2019
Q3
$235K Sell
15,200
-100
-0.7% -$1.3K ﹤0.01% 2886
2019
Q2
$202K Buy
15,300
+500
+3% +$6.82K ﹤0.01% 2966
2019
Q1
$260K Buy
14,800
+3,000
+25% +$47.1K ﹤0.01% 2815
2018
Q4
$135K Hold
11,800
﹤0.01% 2955
2018
Q3
$167K Buy
11,800
+600
+5% +$8.53K ﹤0.01% 3014
2018
Q2
$170K Sell
11,200
-700
-6% -$11.8K ﹤0.01% 3001
2018
Q1
$161K Buy
11,900
+1,400
+13% +$26.6K ﹤0.01% 2903
2017
Q4
$248K Buy
+10,500
New +$248K ﹤0.01% 2787

Other funds holding PLSE

AllianceBernstein's PLSE Position: Q1 2026 in Review

AllianceBernstein reduced its Pulse Biosciences (PLSE) stake by 37% in Q1 2026, selling an estimated $142K and leaving 12,900 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #3074.

AllianceBernstein first reported a position in PLSE in Q4 2017 and has held it in 26 quarters since. The position peaked at $607K in Q4 2020. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • AllianceBernstein held 12,900 shares of Pulse Biosciences worth $177K as of Q1 2026.
  • AllianceBernstein sold 7,720 Pulse Biosciences shares in Q1 2026, an estimated $142K.
  • Pulse Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3074 holding.
  • AllianceBernstein first reported a position in Pulse Biosciences in Q4 2017 and has held it in 26 quarters since.
  • AllianceBernstein's Pulse Biosciences position peaked at $607K in Q4 2020.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.